Shanghai biotech VelaVigo snags $60M after landing two licensing dealsnews2025-07-28T11:14:08+00:00July 28th, 2025|Endpoints News|
TCG Labs Soleil gets another $400M for single-asset biotechs, expands to Chinanews2025-07-24T11:00:39+00:00July 24th, 2025|Endpoints News|
Flagship’s Generate:Biomedicines and Tessera lay off employeesnews2025-07-24T07:42:02+00:00July 24th, 2025|Endpoints News|
Australia-based life sciences VC firm nabs $287M for sixth fundnews2025-07-23T21:00:17+00:00July 23rd, 2025|Endpoints News|
Parker Institute, ARCH unveil CAR-T biotech with $216M to crack solid tumorsnews2025-07-23T10:30:41+00:00July 23rd, 2025|Endpoints News|
Apnimed’s sleep apnea pill clears second Phase 3, setting up FDA filingnews2025-07-23T10:00:51+00:00July 23rd, 2025|Endpoints News|
Medicaid enrollment startup Fortuna Health raises $18Mnews2025-07-22T13:00:22+00:00July 22nd, 2025|Endpoints News|
Avalyn gets $100M to test inhaled pulmonary fibrosis medicinesnews2025-07-22T11:00:43+00:00July 22nd, 2025|Endpoints News|
Sanofi to buy early-stage vaccine maker Vicebio for $1.15B upfrontnews2025-07-22T05:30:33+00:00July 22nd, 2025|Endpoints News|
